Alpine Woods Capital Investors »

Silverback Therapeutics shares owned by Alpine Woods Capital Investors

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Alpine Woods Capital Investors from 13F filings

Historical chart of Alpine Woods Capital Investors investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Alpine Woods Capital Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Alpine Woods Capital Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $80k 10k 8.03

More positions owned by Alpine Woods Capital Investors

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Wells Fargo & Company (WFC)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
L3harris Technologies (LHX)
Agnico (AEM)
Apple (AAPL)
Amgen (AMGN)
Steel Dynamics (STLD)
Cummins (CMI)
Microsoft Corporation (MSFT)
Abbvie (ABBV)
Southern Company (SO)
Pepsi (PEP)

View all positions for Alpine Woods Capital Investors

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Rubric Capital Management
Deerfield Management Company
Millennium Management
BlackRock
Standard Life Aberdeen
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Vanguard Capital Management
UBS Group
Janney Montgomery Scott
Tyro Capital Management

View all funds holding Silverback Therapeutics